• Info
  • Insider Ownership

Insider Trading & Ownership of Blaine Davis

Location
New York, NY
Summary
The estimated net worth of Blaine Davis is at least $866,148 dollars as of 08 Jan 2026. Blaine Davis is the Chief Financial Officer of Cartesian Therapeutics, Inc. and owns shares of Cartesian Therapeutics, Inc. (RNAC) stock worth about $826.7K. Blaine Davis is the Chief Financial Officer of Protara Therapeutics, Inc. and owns shares of Protara Therapeutics, Inc. (TARA) stock worth about $39.5K.
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Blaine Davis
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Blaine Davis and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • Blaine Davis has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $866,148.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Cartesian Therapeutics, Inc. ($826,684).
  • Past-year value change for that position: -$72,227.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Blaine Davis

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RNAC Cartesian Therapeutics, Inc. Chief Financial Officer $826,684 -$72,227 -8% 06 Jan 2026
TARA Protara Therapeutics, Inc. Chief Financial Officer $39,464 15 Jul 2022

Insider Transactions Reported by Blaine Davis:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.